Verseon Mutual Funds | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Verseon Corp.

Verseon Corp. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

CF Woodford Equity Income

30,264,393

19.97%

0.7%

07/31/2018

JPMorgan Funds - Global Healthcare Fund

3,278,432

2.16%

0.2%

05/31/2018

Old Mutual Woodford Equity Income Fund

1,037,000

0.68%

1,037,000

0.93%

07/31/2018

City Financial Absolute Equity Fund

790,000

0.52%

790,000

0.46%

09/29/2017

BNY Mellon Investment Fds. ICVC - Newton Multi-Asset Div. Ret

192,953

0.13%

0.2%

02/28/2018

View Profile

Address	47071 Bayside Parkway Fremont California 94538 United States
Employees	-
Website	http://www.verseon.com
Updated	09/14/2018
Verseon Corp. engages in the development and design of pharmaceutical products. It focuses on drug discovery technology to seed a growing portfolio of programs targeting diverse disease areas, currently consisting of anticoagulation, diabetic macular edema, hereditary angioedema, and oncology. The company was founded by Eniko Fodor, David Kita, and Adityo Prakash in 2002 and is headquartered in Fremont, CA.